Clinical Trials Logo

Biliary Tract Cancer clinical trials

View clinical trials related to Biliary Tract Cancer.

Filter by:

NCT ID: NCT01589328 Completed - Depression Clinical Trials

Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB

EPADE-PB
Start date: March 15, 2012
Phase: N/A
Study type: Interventional

Effect of Early management on PAin and DEpression in patients with PancreatoBiliary Cancer, EPADE-PB Purpose To determine whether early palliative care integrated with usual oncologic care with automated symptom monitoring can improve depression and pain in patients with cancer

NCT ID: NCT01572324 Completed - Clinical trials for Biliary Tract Cancer

Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas

Start date: March 2012
Phase: Phase 2
Study type: Interventional

This Phase II clinical trial is to study the effectiveness and safety of continuous hepatic arterial infusion (HAI) of Oxaliplatin and Fluorouracil in Patients with Unresectable Biliary tract carcinomas, and to explore a better first-line treatment regimen for these patients.

NCT ID: NCT01543607 Terminated - Clinical trials for Biliary Tract Cancer

Endoscopic Therapy of Malignant Bile Duct Strictures

Start date: February 2012
Phase: N/A
Study type: Interventional

Patients with malignant bile duct stenosis have poor prognosis and most of the patients are not good candidate for surgery at the time of diagnosis. Placement of the stent is the palliative care for these patients. However over 50% of the stents get blocked within 6-8 months. Use of the radiofrequency ablation before the stent placement may improve stent patency. Heat will be applied to the bile duct in order to open the blockage and prevent the re-growth of tissue into the stent. The investigators are looking to see how safe and feasible RFA catheter is in patient with malignant bile duct stenosis.

NCT ID: NCT01530503 Completed - Clinical trials for Biliary Tract Cancer

Second Line Therapy in Advanced Biliary Tract Cancer

BIT-2
Start date: November 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the therapeutic activity of capecitabine alone or in combination with mitomycin C as second-line therapy in patients with advanced/metastatic biliary adenocarcinoma in progression after gemcitabine and platinum compounds

NCT ID: NCT01494363 Recruiting - Clinical trials for Biliary Tract Cancer

Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer

Start date: October 2011
Phase: Phase 2
Study type: Interventional

1. Goals The primary goal of this phase II trial is to: evaluate the response rate of combination chemotherapy with Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan in patients with locally advanced or metastatic Biliary tract cancer as first-line chemotherapy Secondary goals are to: evaluate the treatment-related toxicities of this combination, investigate progression-free survival(PFS) and overall survival(OS) in this population 2. Design The proposed clinical trial is an open label, non-comparative, multicenter phase II trial according to the two stage testing design by Simon two-stage testing procedure

NCT ID: NCT01308840 Completed - Clinical trials for Biliary Tract Cancer

Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer

UGIH09067
Start date: December 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine disease response of GEMOX-Panitumumab (GEMOX-P) in KRAS/ BRAF wild-type, Stage IV, biliary tract and gallbladder cancer patients who have previously not received chemotherapy. This study will also examine the potential toxicities, progression-free and overall survival in this population.

NCT ID: NCT01297998 Completed - Clinical trials for Biliary Tract Cancer

A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy

Start date: January 2011
Phase: Phase 1
Study type: Interventional

To decide maximum tolerated dose and recommended dose of treatment using gemcitabine plus cisplatin combination therapy in patients with biliary tract cancer undergoing resection without major hepatectomy.

NCT ID: NCT01294085 Completed - Clinical trials for Biliary Tract Cancer

Case Series Study of Biliary Tract Cancer Patients in Japan

Start date: November 2010
Phase: N/A
Study type: Observational

To assess the difference of prognosis between unresectable and recurrent biliary tract cancer and evaluate prognostic factors.

NCT ID: NCT01291615 Completed - Clinical trials for Biliary Tract Cancer

Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

Start date: December 2010
Phase: Phase 1
Study type: Interventional

To decide maximum tolerated dose and/or recommended dose of Gemcitabine or S-1 adjuvant therapy after hemihepatectomy

NCT ID: NCT01284413 Completed - Clinical trials for Biliary Tract Cancer

Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer

Start date: December 2010
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of this study is to evaluate the safety of GCS therapy for phase I and efficacy of GCS therapy for phase II.